Why the study?
Do dietary weight loss-induced changes in biomarkers (ACE activity, FFA, RBP4) predict weight regain in people with overweight and obesity?
Do dietary weight loss-induced changes in biomarkers (ACE activity, FFA, RBP4) predict weight regain in people with overweight and obesity?
Changes in ACE activity, FFA, and RBP4 during weight loss independently predict subsequent weight regain in individuals with overweight and obesity.
Biomarker shifts during weight loss may flag regain risk for closer monitoring; extends independent predictors in dietary obesity RCTs.
Adipokines and other biomarkers were previously identified with roles in energy expenditure, appetite, satiety, and adiposity. Therefore, we investigated whether dietary weight loss‐induced changes in adipokines and other biomarkers known to play a role in weight regulation or energy expenditure could predict weight regain in people with overweight and obesity. In this randomized controlled trial 26 males and 30 females ( BMI : 28–35 kg/m 2 ) followed either a low‐calorie diet ( LCD ; 1250 kcal/day) for 12 weeks or a very‐low‐calorie diet ( VLCD ; 500 kcal/day) for 5 weeks followed by a weight stable period of 4 weeks (dietary intervention ( DI ) period) and a 9‐month follow‐up period. Blood samples were taken before and after each period to measure FFA , TAG , total cholesterol, insulin, glucose, angiotensin‐converting enzyme ( ACE ) activity, IL ‐6, RBP 4, apelin, leptin, adiponectin, vaspin, and nesfatin‐1 concentrations. Weight loss was similar between groups ( LCD : −8.2 ± 0.5 kg; VLCD : −8.9 ± 0.4 kg, P = 0.30). Only changes in ACE activity, FFA and RBP 4 concentrations during DI were correlated with weight regain in the whole group ( r = −0.299, P = 0.030, r = −0.274, P = 0.047, and r = 0.357, P = 0.008, respectively). Together they explained 28% ( r = 0.532) of weight regain variation. Dietary weight loss‐induced changes in ACE activity, FFA and RBP 4 independently contribute to weight regain prediction.
No takes yet. Share an insight, caveat, or question.
Vink et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: